Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Barclays Capital Conference

Show Health and Fitness Publications

Thu, March 24, 2011

[ Thu, Mar 24th 2011 ] - Market Wire

Gilead fija precio de obligaciones senior no garantizadas por valor de $1.000 millones

[ Thu, Mar 24th 2011 ] - Market Wire

Adamis Reports APC-300 Kills Human Pancreatic Cancer Cells

[ Thu, Mar 24th 2011 ] - Market Wire

CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings

[ Thu, Mar 24th 2011 ] - Market Wire

Baxter International Inc. First Quarter 2011 Financial Results Conference Call

[ Thu, Mar 24th 2011 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval for Lidocaine HCl Jelly, 2%

[ Thu, Mar 24th 2011 ] - Market Wire

Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck

[ Thu, Mar 24th 2011 ] - Market Wire

Abiomed to Host PROTECT II Investor Meeting at ACC 2011

[ Thu, Mar 24th 2011 ] - Market Wire

Geron to Webcast Analyst and Investor Meeting on Companya?s Oncology Programs on March 29, 2011

[ Thu, Mar 24th 2011 ] - Market Wire

West and CareFusion Announce Plans to Develop an Innovative Needle-Free Vented Vial Access Device

[ Thu, Mar 24th 2011 ] - Market Wire

Healthcare Acquisition Activity on the Rise as Key Patents Run Out

[ Thu, Mar 24th 2011 ] - Market Wire

Oncolytics Biotech® Inc. Completes Patient E .. nical Trial Investigating REOLYSIN® in Combi

[ Thu, Mar 24th 2011 ] - Market Wire

Unigenea?s Oral Peptide Drug Delivery Technology .. ine Phase 3 Results from Tarsaa?s ORACAL Trial of

[ Thu, Mar 24th 2011 ] - Market Wire

Fase III klinische trial van Gileads onderzoeksge .. et aan primaire doelstelling voor eerste 48 weken

Wed, March 23, 2011

[ Wed, Mar 23rd 2011 ] - Market Wire

AdCare Health Systems Reports Record Fourth Quarter and Full Year 2010 Results

[ Wed, Mar 23rd 2011 ] - Market Wire

Affymax and Takeda to Present Additional Peginesa .. Patients at the National Kidney Foundation (NKF)

[ Wed, Mar 23rd 2011 ] - Market Wire

El ensayo clnico de Fase III del frmaco en fase d .. itegravir, supera el objetivo principal de 48 sem

[ Wed, Mar 23rd 2011 ] - Market Wire

A.M. Best Withdraws Ratings of Priority Health Ca .. nc. and Peninsula Health Care, Inc. Due to Merger

[ Wed, Mar 23rd 2011 ] - Market Wire

Mesa Uranium Files 43-101 Report, Expands the Green Energy Project

[ Wed, Mar 23rd 2011 ] - Market Wire

Allezoe (ALZM) Announces Organ Transport Systems' Medical Advisory Members

[ Wed, Mar 23rd 2011 ] - Market Wire

Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting

[ Wed, Mar 23rd 2011 ] - Market Wire

Phase III Clinical Trial of Gileada?s Investigational Elvitegravir Meets 48-Week Primary Objective

[ Wed, Mar 23rd 2011 ] - Market Wire

Prana Biotechnology Limited Raises A$6.12 Million in a Private Placement

[ Wed, Mar 23rd 2011 ] - Market Wire

POZEN Announces Licensing Deal with Cilag GmbH, A .. Johnson & Johnson, for MT 400, Migraine Treatment

[ Wed, Mar 23rd 2011 ] - Market Wire

Nordion announces Phase III clinical trial to eva .. or liver metastases in colorectal cancer patients

[ Wed, Mar 23rd 2011 ] - Market Wire

CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction

[ Wed, Mar 23rd 2011 ] - Market Wire

Announcement of the Execution of a License Agreement for Unoprostone

Tue, March 22, 2011

[ Tue, Mar 22nd 2011 ] - Market Wire

New Acetadote® Formulation Now Available in the U.S.

[ Tue, Mar 22nd 2011 ] - Market Wire

Amyris aumenta sua capacidade de produo atrav©s de acordo com a Paraso Bioenergia

[ Tue, Mar 22nd 2011 ] - Market Wire

ISTA Pharmaceuticals Highlights BEPREVE(R) Clinic .. Academy of Allergy, Asthma and Immunology (AAAAI)

[ Tue, Mar 22nd 2011 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup

[ Tue, Mar 22nd 2011 ] - Market Wire

LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO

[ Tue, Mar 22nd 2011 ] - Market Wire

Radient Pharmaceuticals Receives Additional Deficiency Notice From NYSE Amex

[ Tue, Mar 22nd 2011 ] - Market Wire

InSite Vision Announces Positive Phase 1/2 Result .. on of Pain and Inflammation after Cataract Surger

[ Tue, Mar 22nd 2011 ] - Market Wire

POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation

[ Tue, Mar 22nd 2011 ] - Market Wire

Amyris Adds Additional Production Capacity Through Agreement With Paraso Bioenergia

[ Tue, Mar 22nd 2011 ] - Market Wire

Pro-Pharmaceuticals Expands Patent Portfolio with New Patents in the U.S. and Australia

[ Tue, Mar 22nd 2011 ] - Market Wire

Emergent BioSolutions to Present at Needham & Company Healthcare Conference

[ Tue, Mar 22nd 2011 ] - Market Wire

Schiff Nutrition International, Inc. Announces Fiscal 2011 Third Quarter Results

[ Tue, Mar 22nd 2011 ] - Market Wire

Given Imaging to Present at the 10th Annual Needham Healthcare Conference

Mon, March 21, 2011

[ Mon, Mar 21st 2011 ] - Market Wire

2010 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS

[ Mon, Mar 21st 2011 ] - Market Wire

U.S. Physical Therapy to Present at the Sidoti Fi .. nual Emerging Growth Institutional Investor Forum

[ Mon, Mar 21st 2011 ] - Market Wire

Covidien Announces Interim Data Showing Parietex .. Significantly Reduces Early Pain Following Inguin

[ Mon, Mar 21st 2011 ] - Market Wire

[ Mon, Mar 21st 2011 ] - Market Wire

Anacor Pharmaceuticals Secures $30 Million Loan Facility

[ Mon, Mar 21st 2011 ] - Market Wire

RXi Pharmaceuticals Presents New Preclinical RNAi .. one Mechanism and Biology of Silencing Conference

[ Mon, Mar 21st 2011 ] - Market Wire

Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA

[ Mon, Mar 21st 2011 ] - Market Wire

Amyris and U.S. Venture Announce Plans for Joint Venture in Development of Renewable Lubricants

[ Mon, Mar 21st 2011 ] - Market Wire

Biotech Sector Is a Hotbed of Takeover Speculation

[ Mon, Mar 21st 2011 ] - Market Wire

Teleflex Announces Retirement of 2004 Senior Notes

[ Mon, Mar 21st 2011 ] - Market Wire

Given Imaging Wins Patent Infringement Lawsuit in Germany

[ Mon, Mar 21st 2011 ] - Market Wire

XenoPort Reports Results from a Phase 2b Clinical .. il as Adjunctive Treatment for Patients with GERD

[ Mon, Mar 21st 2011 ] - Market Wire

Santarus and Pharming Announce RHUCIN Poster at A .. Allergy, Asthma & Immunology 2011 Annual Meeting

Sun, March 20, 2011

[ Sun, Mar 20th 2011 ] - Market Wire

Curis Announces Positive Results in Genentech Piv .. rial of GDC-0449 in Advanced Basal Cell Carcinoma

Fri, March 18, 2011

[ Fri, Mar 18th 2011 ] - Market Wire

Parere positivo del Comitato per i prodotti medic .. i per uso umano sul nuovo contraccettivo NOMAC-E2

[ Fri, Mar 18th 2011 ] - Market Wire

Forest Laboratories Announces Expiration of Hart- .. o Waiting Period for Acquisition of Clinical Data

[ Fri, Mar 18th 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Therag

[ Fri, Mar 18th 2011 ] - Market Wire

Allezoe (ALZM) Announces Organ Transport Systems .. paring for Clinical Trials; Will Prioritize Heart

[ Fri, Mar 18th 2011 ] - Market Wire

Comit© voor geneesmiddelen voor menselijk gebrui .. deelt positief over nieuwe anticonceptie NOMAC-E2

[ Fri, Mar 18th 2011 ] - Market Wire

CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB

[ Fri, Mar 18th 2011 ] - Market Wire

Rotech Healthcare Inc. Announces Closing of Priva .. Offering of $290 Million Senior Second Lien Notes

[ Fri, Mar 18th 2011 ] - Market Wire

Committee for Medicinal Products for Human Use (C .. Opinion for New Contraception Offering, NOMAC-E2

[ Fri, Mar 18th 2011 ] - Market Wire

Teva Receives Positive Opinion for NOMAC/E2 from the European Committee for Medicinal Products

[ Fri, Mar 18th 2011 ] - Market Wire

Affymax Announces Pricing of Public Offering of Common Stock

[ Fri, Mar 18th 2011 ] - Market Wire

Algoma Central Corporation Announces Increase to Bought Deal Financing

[ Fri, Mar 18th 2011 ] - Market Wire

Cytokinetics Announces Fundamental Research in th .. yosin Activation Published in the Journal Science

[ Fri, Mar 18th 2011 ] - Market Wire

Declarao da Covidien sobre o impacto do terremoto japons

Thu, March 17, 2011

[ Thu, Mar 17th 2011 ] - Market Wire

Covidien Statement on the Impact of the Japanese Earthquake

[ Thu, Mar 17th 2011 ] - Market Wire

HearUSA Responds to Siemens Filing

[ Thu, Mar 17th 2011 ] - Market Wire

SunCoast RHIO Joins Connect HIN - Florida Health Information Network (FLHIN)

[ Thu, Mar 17th 2011 ] - Market Wire

CPEX Pharmaceuticals Advises Stockholders to Take .. Response to Mangrove Partnersa? Revised Proposal

[ Thu, Mar 17th 2011 ] - Market Wire

Antrim Energy Inc. Announces Closing of Financing

[ Thu, Mar 17th 2011 ] - Market Wire

CytRx Begins Phase 1b Clinical Trial with INNO-206 in Patients with Advanced Solid Tumors

[ Thu, Mar 17th 2011 ] - Market Wire

Radient Pharmaceuticals Hires DLA Piper to Defend Company Against Class Action Lawsuit

[ Thu, Mar 17th 2011 ] - Market Wire

Self Funding Administrators Corporation Joins American CareSource's Growing Client Portfolio

[ Thu, Mar 17th 2011 ] - Market Wire

ImmuCell Announces Sales and Marketing Collaboration With AgriLabs

[ Thu, Mar 17th 2011 ] - Market Wire

Prime Equity Research Initiates Independent Coverage On Fresh Start

[ Thu, Mar 17th 2011 ] - Market Wire

Oncolytics Biotech® Inc. Announces 2010 Year End Results

[ Thu, Mar 17th 2011 ] - Market Wire

Alnylam Responds to Tekmira Complaint

[ Thu, Mar 17th 2011 ] - Market Wire

AngioDynamics to Report Fiscal 2011 Third Quarter .. Results and Hold Conference Call on April 5, 2011

Wed, March 16, 2011

[ Wed, Mar 16th 2011 ] - Market Wire

CEO da Covidien deixar o cargo em 1 de julho. Seu Sucessor j foi Nomeado

[ Wed, Mar 16th 2011 ] - Market Wire

El 1 de julio se retira el CEO de Covidien; ya se ha nombrado el sucesor

[ Wed, Mar 16th 2011 ] - Market Wire

Covidien elige como presidente y director ejecutivo a Jose E. Almeida

[ Wed, Mar 16th 2011 ] - Market Wire

St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant

[ Wed, Mar 16th 2011 ] - Market Wire

PATIENT HOME MONITORING ANNOUNCES NEW CHIEF FINANCIAL AND OPERATIONS OFFICER

[ Wed, Mar 16th 2011 ] - Market Wire

Study Shows SANUWAVEa?s Dermapace is Significantl .. ric Oxygen Therapy in Healing Chronic Diabetic Fo

[ Wed, Mar 16th 2011 ] - Market Wire

Covidien Elects Jose E. Almeida President and Chief Executive Officer

[ Wed, Mar 16th 2011 ] - Market Wire

Covidien CEO to Retire July 1; Successor Named

[ Wed, Mar 16th 2011 ] - Market Wire

Covidiens CEO scheidet am 1. Juli aus dem Amt; Nachfolger ernannt

[ Wed, Mar 16th 2011 ] - Market Wire

CEO di Covidien in pensione dal 1 luglio - nominato successore

[ Wed, Mar 16th 2011 ] - Market Wire

TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2010 .. SCAL RESULTS AND UPDATES ON SUBSEQUENT ACTIVITIES

[ Wed, Mar 16th 2011 ] - Market Wire

Amedisys Presents Home Care and Hospice Face-to-Face Requirements Webinar to Health Care Leaders

[ Wed, Mar 16th 2011 ] - Market Wire

AlphaRx Provides Corporate and Development Update

Tue, March 15, 2011

[ Tue, Mar 15th 2011 ] - Market Wire

Covidien bepaalt contant kwartaaldividend en maak .. n van jaarlijkse algemene vergadering 2011 bekend

[ Tue, Mar 15th 2011 ] - Market Wire

Covidien Declares Quarterly Cash Dividend and Announces Results from 2011 Annual General Meeting

[ Tue, Mar 15th 2011 ] - Market Wire

Covidien setzt vierteljhrliche Bardividende fest .. ibt Ergebnisse der Jahresversammlung 2011 bekannt

[ Tue, Mar 15th 2011 ] - Market Wire

Covidien d©clare un dividende trimestriel en esp .. les r©sultats de son assembl©e g©n©rale 2011

[ Tue, Mar 15th 2011 ] - Market Wire

Exelixis Announces Exercise in Full of Option to .. es and Closing of Public Offering of Common Stock

[ Tue, Mar 15th 2011 ] - Market Wire

Concentra Successfully Deploys ZeOmegaa?s Integrated Workflow Solution

[ Tue, Mar 15th 2011 ] - Market Wire

Seattle Genetics and Millennium Expand Antibody-Drug Conjugate Collaboration

[ Tue, Mar 15th 2011 ] - Market Wire

Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2010 Financial Results

[ Tue, Mar 15th 2011 ] - Market Wire

Unigene Doses First Patient in Phase 2 Oral PTH S .. Treatment of Osteoporosis in Postmenopausal Women

[ Tue, Mar 15th 2011 ] - Market Wire

Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents

[ Tue, Mar 15th 2011 ] - Market Wire

Merck to Present at Barclays Capital 2011 Global Healthcare Conference

[ Tue, Mar 15th 2011 ] - Market Wire

Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results

[ Tue, Mar 15th 2011 ] - Market Wire

Illumina Prices $800 Million Convertible Senior Notes

Mon, March 14, 2011

[ Mon, Mar 14th 2011 ] - Market Wire

Incytea?s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study

[ Mon, Mar 14th 2011 ] - Market Wire

Teva to Present at the Barclays Capital 2011 Global Healthcare Conference

[ Mon, Mar 14th 2011 ] - Market Wire

Health Net, Inc. Investigating Unaccounted-for Server Drives

[ Mon, Mar 14th 2011 ] - Market Wire

[ Mon, Mar 14th 2011 ] - Market Wire

Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging

[ Mon, Mar 14th 2011 ] - Market Wire

Bristol-Myers Squibb Awards Grant to the American .. tion to Address U.S. HIV Medical Workforce Shorta

[ Mon, Mar 14th 2011 ] - Market Wire

HemaCare Reports Fourth Quarter and Year End Results

[ Mon, Mar 14th 2011 ] - Market Wire

Medtronic Announces Global Launch of New Heart Va .. Ring Designed to Adapt to Hearta?s Natural Valve

[ Mon, Mar 14th 2011 ] - Market Wire

Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011

[ Mon, Mar 14th 2011 ] - Market Wire

Anacor Pharmaceuticals Completes Enrollment in Phase 2b Trial of AN2728 for Psoriasis

[ Mon, Mar 14th 2011 ] - Market Wire

Repligen Announces Conference Call to Discuss Pha .. cal Trial Results of RG1068 in Pancreatic Imaging

[ Mon, Mar 14th 2011 ] - Market Wire

Covidien Announces New Data on Hernia and Abdomin .. ir Products to Be Presented at Hernia Repair 2011

[ Mon, Mar 14th 2011 ] - Market Wire

Human Genome Sciences Appoints George Morrow to its Board of Directors

Sun, March 13, 2011

[ Sun, Mar 13th 2011 ] - Market Wire

DaVita Enhances Already Strong Governance Policies

Sat, March 12, 2011

[ Sat, Mar 12th 2011 ] - Market Wire

Gilead raccomanda di rifiutare la?offerta di minigara presentata da TRC Capital Corporation

[ Sat, Mar 12th 2011 ] - Market Wire

Gilead empfiehlt Ablehnung von Mini-bernahmeangebot durch TRC Capital Corporation

[ Sat, Mar 12th 2011 ] - Market Wire

Gilead Adviseert Afwijzing van Mini-Overnamebod door TRC Capital Corporation

Fri, March 11, 2011

[ Fri, Mar 11th 2011 ] - Market Wire

The Rosen Law Firm Files Class Action Lawsuit Cha .. ceuticals Corporation With Securities Fraud - RPC

[ Fri, Mar 11th 2011 ] - Market Wire

Edwards Lifesciences Acquires Embrella Cardiovascular, Inc.

[ Fri, Mar 11th 2011 ] - Market Wire

Aetna Recognized by the National Business Group on Health for Reducing Disparities in Care

[ Fri, Mar 11th 2011 ] - Market Wire

Orthofix Sports Medicine Launches Three New Products in March

[ Fri, Mar 11th 2011 ] - Market Wire

Obagi Medical Products to Present at the 23rd Annual Roth OC Growth Stock Conference

[ Fri, Mar 11th 2011 ] - Market Wire

NovaDel Pharma Inc. to Present at ROTH 23rd Annual OC Growth Stock Conference

[ Fri, Mar 11th 2011 ] - Market Wire

Human Genome Sciences oraz GlaxoSmithKline oglasz .. DA na wprowadzenie na rynek BENLYSTA® (Belimumab

[ Fri, Mar 11th 2011 ] - Market Wire

Equity Research on Elan Corp. plc and Valeant Pha .. Drug Delivery Sector Sees Opportunities and Growi

[ Fri, Mar 11th 2011 ] - Market Wire

CytRx Reports 2010 Financial Results

[ Fri, Mar 11th 2011 ] - Market Wire

Synta Announces Clinical Program Updates and 2010 Financial Results

[ Fri, Mar 11th 2011 ] - Market Wire

Human Genome Sciences????????????BENLYSTA® (?????) ?FDA??????????????

[ Fri, Mar 11th 2011 ] - Market Wire

Centric Health Reports Solid 2010 Financial Results

[ Fri, Mar 11th 2011 ] - Market Wire

Covidien????????????????FDA??

Thu, March 10, 2011

[ Thu, Mar 10th 2011 ] - Market Wire

Covidien recibe la autorizacin de la FDA para los .. basados en uranio de bajo enriquecimiento produci

[ Thu, Mar 10th 2011 ] - Market Wire

Covidien obtient la?approbation de la FDA pour un .. rique du Sud bas© sur de la?uranium faiblement e

[ Thu, Mar 10th 2011 ] - Market Wire

A Brighter Decade Ahead for Biotech - In-Depth Re .. ch Featuring Biodel Inc. and MannKind Corporation

[ Thu, Mar 10th 2011 ] - Market Wire

Anacor Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results

[ Thu, Mar 10th 2011 ] - Market Wire

CompCare Expands Management Team to Drive Continued Innovation and Bottom-Line Growth

[ Thu, Mar 10th 2011 ] - Market Wire

Northstar Healthcare Reports 2010 Results

[ Thu, Mar 10th 2011 ] - Market Wire

Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications

[ Thu, Mar 10th 2011 ] - Market Wire

Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results

[ Thu, Mar 10th 2011 ] - Market Wire

Human Genome Sciences e GlaxoSmithKline annuncian .. zione da parte dell'FDA per il BENLYSTA® (belimu

[ Thu, Mar 10th 2011 ] - Market Wire

Santarus Initiates Phase I Clinical Study with SAN-300

[ Thu, Mar 10th 2011 ] - Market Wire

BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering

[ Thu, Mar 10th 2011 ] - Market Wire

Human Genome Sciences und GlaxoSmithKline melden .. (Belimumab) zur Behandlung von systemischem Lupus

[ Thu, Mar 10th 2011 ] - Market Wire

Human Genome Sciences et GlaxoSmithKline annoncen .. ur BENLYSTA® (Belimumab) dans le traitement du l

Wed, March 9, 2011

[ Wed, Mar 09th 2011 ] - Market Wire

The Law Offices of Vincent Wong Announce an Inves .. hes of Fiduciary Duty by the Board of TomoTherapy

[ Wed, Mar 09th 2011 ] - Market Wire

A.M. Best Revises Outlook to Stable for Coventry Health Care, Inc. and Its Subsidiaries

[ Wed, Mar 09th 2011 ] - Market Wire

Renegade Petroleum Ltd. Announces Closing of $41.9 Million Bought Deal Financing

[ Wed, Mar 09th 2011 ] - Market Wire

Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs

[ Wed, Mar 09th 2011 ] - Market Wire

Fight Colorectal Cancer and Genomic Health Launch Unique Online Resource for Colon Cancer Patients

[ Wed, Mar 09th 2011 ] - Market Wire

Avid Bioservices to Present Comparability Studies .. ge-Scale Manufacturing of Clinical-Stage Antibody

[ Wed, Mar 09th 2011 ] - Market Wire

Corcept Therapeutics Announces Fourth Quarter Results and Corporate and Development Update

[ Wed, Mar 09th 2011 ] - Market Wire

Biotech's Response to the MRSA Epidemic

[ Wed, Mar 09th 2011 ] - Market Wire

DUSA Pharmaceuticals to Present at Roth Capital Partners 23rd Annual OC Growth Stock Conference

[ Wed, Mar 09th 2011 ] - Market Wire

Opexa Therapeutics Reports Year End 2010 Financial Results and Provides Corporate Update

[ Wed, Mar 09th 2011 ] - Market Wire

Biomagnetics to Receive Funding From BIOTECH Deve .. pment Partners for Commercialization of Biosensor

[ Wed, Mar 09th 2011 ] - Market Wire

Hythiam to Present at the Roth 23rd Annual OC Growth Stock Conference

[ Wed, Mar 09th 2011 ] - Market Wire

Lilly CEO Calls for Biopharmaceutical Industry Ch .. es and Policies That Encourage Medical Innovation

Tue, March 8, 2011

[ Tue, Mar 08th 2011 ] - Market Wire

Medtronic CareLink® Network Remote Monitoring He .. Improve Patient Care and Reduce Healthcare Costs

[ Tue, Mar 08th 2011 ] - Market Wire

Derma Sciences to Present at the Roth Capital Partners Growth Stock Conference

[ Tue, Mar 08th 2011 ] - Market Wire

China Kanghui Holdings Announces Participation in Upcoming Investor Events

[ Tue, Mar 08th 2011 ] - Market Wire

Arrowhead Research to Present at the Roth Capital .. 3rd Annual OC Growth Stock Conference on March 16

[ Tue, Mar 08th 2011 ] - Market Wire

ZIOPHARM to Present at Barclays Capital 2011 Global Healthcare Conference

[ Tue, Mar 08th 2011 ] - Market Wire

Yellowhead Mining Reports Positive Results of Preliminary Economic Assessment

[ Tue, Mar 08th 2011 ] - Market Wire

Marina Biotech, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference

[ Tue, Mar 08th 2011 ] - Market Wire

Dynavax Reports Fourth Quarter and Year End 2010 Financial Results

[ Tue, Mar 08th 2011 ] - Market Wire

Applied DNA Sciences, Inc. Migrates to the OTCQB Tier of the OTC Marketplace

[ Tue, Mar 08th 2011 ] - Market Wire

Cytori Patents Method of Making Stem and Regenerative Cell-Enriched Fat Grafts

[ Tue, Mar 08th 2011 ] - Market Wire

Peregrine Announces Initiation of Lung Cancer Investigator-Sponsored Trial

[ Tue, Mar 08th 2011 ] - Market Wire

GTSO JV Secures NewRare Earth Mining Lease in Mongolia

[ Tue, Mar 08th 2011 ] - Market Wire

Healthways Announces Planned Transition of President, Stefen Brueckner, to Senior Advisor Role

Mon, March 7, 2011

[ Mon, Mar 07th 2011 ] - Market Wire

Law Offices of Howard G. Smith Announces Investig .. rs of TomoTherapy Incorporated, in Connection wit

[ Mon, Mar 07th 2011 ] - Market Wire

Prana to Present at Cowen and Company Health Care Conference

[ Mon, Mar 07th 2011 ] - Market Wire

TomoTherapy Incorporated Shareholder Investigatio .. m Concerning Sale to Accuray Incorporated a" TOMO

[ Mon, Mar 07th 2011 ] - Market Wire

Kendall Law Group Investigates TomoTherapy Inc. Acquisition for Shareholders

[ Mon, Mar 07th 2011 ] - Market Wire

Rigrodsky & Long, P.A. Investigates Buyout of TomoTherapy Incorporated - TOMO

[ Mon, Mar 07th 2011 ] - Market Wire

Stellar's Common Shares Now Trading on OTCQB

[ Mon, Mar 07th 2011 ] - Market Wire

Daxor Announces Publication of Research Article D .. 100 Data to Guide Shock Resuscitation Led to Sign

[ Mon, Mar 07th 2011 ] - Market Wire

Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results

[ Mon, Mar 07th 2011 ] - Market Wire

Allied Healthcare International Inc. Acquires ScotHomecare

[ Mon, Mar 07th 2011 ] - Market Wire

Amedisys to Present at the Raymond James and Asso .. es 32nd Annual Institutional Investors Conference

[ Mon, Mar 07th 2011 ] - Market Wire

Rotech Healthcare Inc. Announces Proposed Private .. Offering of $290 Million Senior Second Lien Notes

[ Mon, Mar 07th 2011 ] - Market Wire

Compugen Announces Positive Animal Model Results .. de Predicted to Block Protein-Protein Interaction

[ Mon, Mar 07th 2011 ] - Market Wire

ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia

Sat, March 5, 2011

[ Sat, Mar 05th 2011 ] - Market Wire

Harper Creek Drill Hole HC10-82 Confirms Minerali .. thern Limit of Drill Holes in 2010 Resource Model

Fri, March 4, 2011

[ Fri, Mar 04th 2011 ] - Market Wire

DaVita Is Recognized for Clinical and Operational Excellence Early in 2011

[ Fri, Mar 04th 2011 ] - Market Wire

U.S. FDA Removes Warning about Potential Liver In .. of Prescribing Information for Gilead's Letairis

[ Fri, Mar 04th 2011 ] - Market Wire

Lannett Comments on News Article

[ Fri, Mar 04th 2011 ] - Market Wire

CPEX Receives Letter from Athyrium Capital Management

[ Fri, Mar 04th 2011 ] - Market Wire

Helix BioPharma Corp. Announces Fiscal Q2 2011 Results

[ Fri, Mar 04th 2011 ] - Market Wire

BURCON ENTERS LICENSE AGREEMENT WITH ADM FOR CLARISOY® PROTEIN TECHNOLOGY

[ Fri, Mar 04th 2011 ] - Market Wire

America Service Group, Inc. Shareholder Investiga .. erning Acquisition by Valitas Health Services, In

[ Fri, Mar 04th 2011 ] - Market Wire

Law Offices of Howard G. Smith Announces Investig .. rs of America Service Group Inc., in Connection w

[ Fri, Mar 04th 2011 ] - Market Wire

Court Ruling Clears Way for Jury Trial in $1 Billion Texas Medicaid Whistleblower Lawsuit

[ Fri, Mar 04th 2011 ] - Market Wire

D. Medical to Release Fiscal 2010 Fourth Quarter .. cial Results on March 9-Conference Call to Follow

[ Fri, Mar 04th 2011 ] - Market Wire

Prana's Co-Founding Scientist Awarded Prestigious Australia Fellowship

[ Fri, Mar 04th 2011 ] - Market Wire

Regulatory Approval an Ongoing Challenge for Drug Makers

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Barclays Capital Conference

_{//health-fitness.news-articles.net/content/2011/ .. presentation-at-barclays-capital-conference.html}
^{Published in Health and Fitness on Monday, March 14th 2011 at 13:10 GMT by Market Wire}

ROCKVILLE, Md.--([ BUSINESS WIRE ])--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the Barclays Capital 2011 Global Healthcare Conference will be webcast and may be accessed at [ www.hgsi.com ].

A member of Human Genome Sciencesa� senior management team will present a corporate overview on Thursday, March 17, 2011, at 9:00 AM Eastern time. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

About Human Genome Sciences

Human Genome Sciences exists to place new therapies into the hands of those battling serious disease.

For more information about HGS, please visit the Companya�s web site at [ www.hgsi.com ]. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to [ medinfo@hgsi.com ] or by calling HGS at (877) 822-8472. HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. Other trademarks referenced are the property of their respective owners.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire